| Transaction Date | Filer | Title | Filing | Transaction Type | Shares Traded | Price | Total Held* |
|---|---|---|---|---|---|---|---|
| Feb 14, 2024 | Corp VP & General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,332 | -- | 7,620 | |
| Feb 14, 2024 | Corp VP & General Counsel | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,919 | -- | 5,701 | |
| Feb 14, 2024 | Director, Chair, CEO and President | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 45,832 | -- | 207,063 | |
| Feb 14, 2024 | Director, Chair, CEO and President | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 20,335 | $446.37 | 186,728 | |
| Feb 14, 2024 | Director, Chair, CEO and President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,155 | -- | 48,363 | |
| Feb 14, 2024 | Director, Chair, CEO and President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 37,636 | -- | 119,044 | |
| Feb 14, 2024 | Director, Chair, CEO and President | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 45,832 | -- | 73,212 | |
| Dec 31, 2023 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 96 | $468.14 | 9,145 | |
| Dec 31, 2023 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 75 | $468.14 | 882 | |
| Dec 31, 2023 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 45 | $468.14 | 1,353 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.